Congenital Hyperinsulinism is a life-threatening condition where too much insulin causes dangerously low blood sugar. Genetic testing is required to guide medical management. Sadly, babies in resource-poor countries cannot access this.
To address these inequities, the team partnered with Congenital Hyperinsulinism International (CHI) and the NHS, National Hyperinsulinism Genetics Laboratory to establish a charity-funded testing service for those in need. Individuals were also invited to enrol in research to improve knowledge of the genetics and natural history of hyperinsulinism.
Through this initiative, they managed to turn the constraints of limited resources into an advantage for scientific progress, whilst improving the health of children worldwide.Back home Back to the main news page